Abstract:OBJECTIVE:To investigate the cardioprotective effects of sodium ferulate (SF) mediated by nitric oxide on ischemia-reperfusion injured myocardium. METHODS:Fifty-six SD rats were killed. Their hearts were isolated and randomly divided into 7 equal groups: ischemia/reperfusion group (I/R group), ischemic/preconditioning (IP group, to be perfumed with anoxic and reoxygenated fluid several times so as to produce protection against continuous and severe ischemia), SF pretreatment group (to be perfused with fluid with SF and then made I/R model), L-NAME + SF group (to be perfused with fluid with SF and L-NAME, a NO inhibitor, and then made I/R model), glibenclamide (Glib) + SF group (to be perfused with Glib + SF and then made I/R model)), L-NAME + Glib + SF group (to be perfused with L-NAME + Glib + SF and then made I/R model)), and control group (normal isolated hearts). Electrocardiography was conducted and left ventricular systolic pressure (LVSP), dp/dt(max), and heart rate (HR) were measured. By the end of the experiment 0.5 grams of tissue was taken from the left ventricle. The levels of superoxide dismutase (SOD), malonyldialdehyde (MOD), NO, and cyclic guanosine monophosphate (cGMP) were detected. RESULTS:The levels of LVSP, dp/dt(max), and HR of the SF pretreatment group and IP group were all significantly higher than those of the I/R group (all P < 0.01) without significant differences between these 2 groups (all P > 0.05). The levels of LVSP, dp/dt(max), and HR of the L-NAME, Glib + SF, and L-NAME + Glib + SF groups were all significantly lower than those of the SF pretreatment group and IP group (all P < 0.01). Ventricular extrasystole (VE) and ventricular tachycardia (VT) during re-perfusion period occurred in all hearts of the I/R group, however, the incidence rates of VE and VT of the IP and SF groups were all significantly lower than those of the I/R group (all P < 0.01), however, without significant differences between the IP and SF groups (all P > 0.05). The incidence rate of VE and VT of the L-NAME, Glib + SF, and L-NAME + Glib + SF groups were all significantly higher than those of the SF group (all P < 0.01). The myocardium MDA content of the I/R group was significantly higher and the SOD activity significantly lower in comparison with the control group (both P < 0.01); the myocardium MDA contents of the IP and SF groups were significantly lower and the SOD activity levels significantly higher in comparison with the I/R group (all P < 0.01), however, with significant differences between theses 2 groups (both P > 0.05); the myocardium MDA contents were significantly higher and the SOD activity levels significantly lower in the L-NAME, Glib + SF, and L-NAME + Glib + SF groups in comparison with the SF and IP groups (all P < 0.01). The myocardium NO(2)(-)/NO(3)(-) and cGMP contents of the I/R group were both significantly lower than those of the control group (both P < 0.01), and the myocardium NO(2)(-)/NO(3)(-) and cGMP contents of the IP and SF groups were both significantly higher than those of the I/R group (both P < 0.01), however, without significant differences between these 2 groups (both P > 0.05). The myocardium NO(2)(-)/NO(3)(-) and cGMP contents of the L-NAME, Glib + SF, and L-NAME + Glib + SF groups were all significantly lower than those of the SF group (all P < 0.01). CONCLUSION:SF pretreatment significantly improves the releasing of NO, decreases oxygen free radicals, and relieves myocardial ischemia reperfusion injury. The opening of the ATP-sensitive potassium channels induced by the cGMP way of NO activation may be an important pathway in the cardioprotective effects of SF pretreatment.

[Synthesis and Cardioprotective Effect of a Novel Anti-Ischemic/reperfused Injury Compound].

[Auricularia Auricular Polysaccharide Protects Myocardium Against Ischemia/reperfusion Injury].

Protective effect of Acetyl Danshen Acid Isosorbide Mononitrate on myocardial ischemia/reperfusion injury in rats

Cardioprotective Effects of Sodium Ferulate Mediated by Nitric Oxide on Ischemia-Reperfusion Injured Myocardium: Experiment with Isolated Rat Hearts

A novel small molecule compound VCP979 improves ventricular remodeling in murine models of myocardial ischemia/reperfusion injury

A Novel Ferulic Acid Derivative Attenuates Myocardial Cell Hypoxia Reoxygenation Injury Through a Succinate Dehydrogenase Dependent Antioxidant Mechanism.

Cardioprotective effects of Amentoflavone by suppression of apoptosis and inflammation on an in vitro and vivo model of myocardial ischemia-reperfusion injury

Cardioprotective effect of SMND-309, a novel derivate of salvianolic acid B on acute myocardial infarction in rats

Enhanced cardioprotective activity of ferulic acid-loaded solid lipid nanoparticle in an animal model of myocardial injury

Cardioprotective Effect of the Aqueous Extract of Lavender Flower Against Myocardial Ischemia/Reperfusion Injury

AFC1 Compound Attenuated MI/R-Induced Ventricular Remodeling via Inhibiting PDGFR and STAT Pathway

TARGETED COMBINATION AND ANTI-INFLAMMATORY EFFECTS OF ANTI-INTERCELLULAR ADHESION MOLECULE 1 TARGETED PERFLUOROOCTYLBROMIDE PARTICLES ON MYOCARDIAL ISCHEMIA-REPERFUSION INJURY IN RAT MODEL

Effects of Shenfu injection on myocardial adenosine receptors in rats with myocardial ischemia-reperfusion postconditioning

Protective Effect of Compound Shenfu Injection on Isolated Rat Myocardium with Anoxia/reoxygenation

Water-soluble Acacetin Prodrug Confers Significant Cardioprotection Against Ischemia/reperfusion Injury

Effect of Sodium Ferulate on Myocardial Ischemia Fibrosis Induced by Isoproterenol

A study on the relationship between succinate dehydrogenase and mitoKATPC in the mechanism of ischemic postconditioning protecting against MIRI under CPB in adult rats

Design and Synthesis of Matrine Derivatives for Anti Myocardial Ischemia–reperfusion Injury by Promoting Angiogenesis

Delayed protection of sodium ferulate on isolated rat hearts mediated by bradykinin

Ameliorative effect of ferruginol on isoprenaline hydrochloride-induced myocardial infarction in rats

Cardioprotective effect of 'methylamine irisolidone', a new compound, in hypoxia/reoxygenation injury in cultured rat cardiac myocytes.